Simple Summary The cross-talk between neoplastic cells and microenvironment is known to
play a crucial role in tumor development as well as in the phenomenon of resistance to …

Breast cancer is the most frequent cancer in women worldwide. Despite the improvement in
diagnosis and treatments, the rates of cancer relapse and resistance to therapies remain …

Breast cancer is the most common malignancy and leading cause of cancer mortality in
women. Drug resistance is a major obstacle in systemic therapy of breast cancer, which …

MicroRNAs (miRNAs) are small noncoding RNA molecules with big implications in cancer.
The abnormal expression of specific miRNAs has been linked to development of many …

Despite advances in detection and therapies, breast cancer is still the leading cause of
cancer death in women worldwide. The etiology of this neoplasm is complex, and both …

Breast cancer (BC) formation is primarily influenced by genetics, epigenetics and
environmental factors. Aberrant Genetics and epigenetics leads to a condition known as …

MicroRNAs, short non-coding single-stranded RNAs, are important regulators and
gatekeepers of the coding genes in the human genome. MicroRNAs are highly conserved …

MicroRNAs (miRNAs) are small non-coding RNA molecules that critically regulate the
expression of genes. MiRNAs are involved in physiological cellular processes; however …

Intrinsic or acquired resistance to commonly used therapeutic agents is a major challenge in
treating cancer patients. Decades of research have unraveled several unique and common …

ABSTRACT Preclinical Research Breast cancer is the most prevalent malignancy in women
with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical …